What is the true risk of a pharmacokinetic drug–drug interaction?

By Fuhr Uwe  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 10, 2007-10 ,pp. : 897-899

Springer Publishing Company

Access to resources Recommend Favorite

Semi-Mechanistic Population Pharmacokinetic Drug-Drug Interaction Modelling of a Long Half-Life Substrate and Itraconazole

By Lehr Thorsten   Staab Alexander   Trommeshauser Dirk   >   Kloft Charlotte  

Clinical Pharmacokinetics, Vol. 49, Iss. 1, 2010-01 ,pp. : 53-66

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Drug–Drug Interaction of the Novel Anticancer Agent E7070 and Acenocoumarol

By van den Bongard H.J.G. Desirée   Sparidans Rolf W.   Critchley David J.P.   Beijnen Jos H.   Schellens Jan H.M.  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 151-158

Springer Publishing Company

Access to resources Recommend Favorite

Lack of Pharmacokinetic Drug-Drug Interaction between Orlistat and Cerivastatin

By Mück W.   Adelmann H-G.   Ruf T.   Unger S.   Voith B.  

Clinical Drug Investigation, Vol. 19, Iss. 1, 2000-01 ,pp. : 71-73

Adis International

Access to resources Recommend Favorite

Drug-Drug Interaction Prediction Assessment

By Zhou Jihao  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 4, 2009-07 ,pp. : 641-657

Taylor & Francis Ltd

Access to resources Recommend Favorite